Cerebralcare Granule® Enhances Memantine Hydrochloride Efficacy in APP/PS1 Mice by Ameliorating Amyloid Pathology and Cognitive Functions

Overview

Journal Chin Med

Publisher Biomed Central

Specialty Biomedical Engineering

Date 2021 Jun 29

PMID 34183022

Citations 1

Authors

Ou Qiao

Xinyu Zhang

Yi Zhang

Haixia Ji

Zhi Li

Xiaoying Han

Wenzhe Wang

Xia Li

Juan Wang

Changxiao Liu

Wenyuan Gao

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory deficits and cognitive decline. Current drugs can only relieve symptoms, but cannot really cure AD. Cerebralcare Granule® (CG) is a Traditional Chinese medicine (TCM) containing a variety of biologically active compounds. In our previous studies, CG has shown a beneficial effect against memory impairment in mice caused by D-galactose. However, whether CG can be used as a complementary medicine for the treatment of AD remains unexplored. Here, we use a combination of CG and memantine hydrochloride (Mm) to treat Alzheimer-like pathology and investigate the effects and mechanisms in vivo.

Methods: The histology of brain was examined with Hematoxylin-eosin (HE) staining, Golgi staining and Thioflavin S staining. ELISA was applied to assess the expression levels or activities of CAT, SOD, GSH-Px, MDA, alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bilirubin (TBIL) in serum, as well as the levels of IL-6, IL-1β, and TNF-α in the mice brain. Western blotting was used to assess the expression of β-secretase (BACE1), amyloid precursor protein (APP), APPβ, APPα, synaptophysin (SYN), growth-associated protein 43 (GAP43), and postsynaptic density 95 (PSD95).

Results: In the present study, the combination group (CG + Mm) significantly attenuated Alzheimer-like behavior without adverse effects in APP/PS1 mice, indicating its high degree of safety and efficacy after long-term treatment. CG + Mm reduced AD pathological biomarker Aβ plaque accumulation by inhibiting BACE1 and APP expression (P < 0.05 or P < 0.001). Besides, the combination group markedly inhibited the levels of IL-1β, IL-6, and TNF-α in hippocampus (P < 0.001), as well as activities of SOD, CAT, and GSH-Px in serum (P < 0.001). By contrast, the combination group improved synaptic plasticity by enhancing SYN, PSD95, and GAP43 expression.

Conclusions: Taken together, these data supported the notion that CG combined with Mm might ameliorate the cognitive impairment through multiple pathways, suggesting that CG could play a role as complementary medicine to increase anti-AD effect of chemical drugs by reducing Aβ deposition, neuroinflammation, oxidative damage, and improving synaptic plasticity.

Citing Articles

Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment.

Xiong Y, Huang J Chin Med. 2021; 16(1):80.

PMID: 34407830 PMC: 8371597. DOI: 10.1186/s13020-021-00489-0.

References

Selkoe D, Schenk D . Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2002; 43:545-84. DOI: 10.1146/annurev.pharmtox.43.100901.140248. View

Mori T, Koyama N, Tan J, Segawa T, Maeda M, Town T . Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice. J Biol Chem. 2018; 294(8):2714-2731. PMC: 6393618. DOI: 10.1074/jbc.RA118.004280. View

Xia D, Huang X, Bi C, Mao L, Peng L, Qian H . PGC-1α or FNDC5 Is Involved in Modulating the Effects of Aβ Oligomers on Suppressing the Expression of BDNF, a Beneficial Factor for Inhibiting Neuronal Apoptosis, Aβ Deposition and Cognitive Decline of APP/PS1 Tg Mice. Front Aging Neurosci. 2017; 9:65. PMC: 5359257. DOI: 10.3389/fnagi.2017.00065. View

Wang X, Zhao H, Liu L, Niu P, Zhai C, Li J . Hejie Zhitong prescription promotes sleep and inhibits nociceptive transmission-associated neurotransmitter activity in a rodent migraine model. Chin Med. 2020; 15:105. PMC: 7526328. DOI: 10.1186/s13020-020-00386-y. View

El-Husseini A, Schnell E, Chetkovich D, Nicoll R, Bredt D . PSD-95 involvement in maturation of excitatory synapses. Science. 2000; 290(5495):1364-8. View

Xia J, Rong L, Sawakami T, Inagaki Y, Song P, Hasegawa K . Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma. Biomed Pharmacother. 2018; 99:921-930. DOI: 10.1016/j.biopha.2018.01.163. View

Zhang X, Ding Y, Chen J, Xiao X, Zhang W, Zhou L . Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules. J Ethnopharmacol. 2020; 261:113067. DOI: 10.1016/j.jep.2020.113067. View

Ding B, Zhou T, Fan G, Hong Z, Wu Y . Qualitative and quantitative determination of ten alkaloids in traditional Chinese medicine Corydalis yanhusuo W.T. Wang by LC-MS/MS and LC-DAD. J Pharm Biomed Anal. 2007; 45(2):219-26. DOI: 10.1016/j.jpba.2007.06.009. View

Chen L, Qi J, Chang Y, Zhu D, Yu B . Identification and determination of the major constituents in Traditional Chinese Medicinal formula Danggui-Shaoyao-San by HPLC-DAD-ESI-MS/MS. J Pharm Biomed Anal. 2009; 50(2):127-37. DOI: 10.1016/j.jpba.2009.03.039. View

10.

Qu Z, Yang H, Zhang J, Huo L, Chen H, Li Y . Cerebralcare Granule(®), a Chinese Herb Compound Preparation, Attenuates D-Galactose Induced Memory Impairment in Mice. Neurochem Res. 2016; 41(9):2199-214. DOI: 10.1007/s11064-016-1934-9. View

11.

Ren P, Chen J, Li B, Zhang M, Yang B, Guo X . Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress. Oxid Med Cell Longev. 2020; 2020:3050971. PMC: 7238335. DOI: 10.1155/2020/3050971. View

12.

Lee T, Kang I, Kim B, Sim H, Kim D, Ahn J . Experimental Pretreatment with Chlorogenic Acid Prevents Transient Ischemia-Induced Cognitive Decline and Neuronal Damage in the Hippocampus through Anti-Oxidative and Anti-Inflammatory Effects. Molecules. 2020; 25(16). PMC: 7463954. DOI: 10.3390/molecules25163578. View

13.

Li Z, Li H, Zhao C, Lv C, Zhong C, Xin W . Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation. CNS Neurol Disord Drug Targets. 2015; 14(3):360-9. DOI: 10.2174/1871527314666150225141521. View

14.

Kong Y, Peng Q, Lv N, Yuan J, Deng Z, Liang X . Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer's disease via activation of adenosine A receptor. Neurosci Lett. 2020; 730:135016. DOI: 10.1016/j.neulet.2020.135016. View

15.

Masliah E, Mallory M, Alford M, DeTeresa R, Hansen L, McKeel Jr D . Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology. 2001; 56(1):127-9. DOI: 10.1212/wnl.56.1.127. View

16.

Wang D, Liu L, Li S, Wang C . Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive impairment in mice. Physiol Behav. 2018; 191:12-20. DOI: 10.1016/j.physbeh.2018.03.016. View

17.

Cummings J, Lee G, Ritter A, Zhong K . Alzheimer's disease drug development pipeline: 2018. Alzheimers Dement (N Y). 2018; 4:195-214. PMC: 6021548. DOI: 10.1016/j.trci.2018.03.009. View

18.

Thingore C, Kshirsagar V, Juvekar A . Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice. Metab Brain Dis. 2020; 36(2):299-313. DOI: 10.1007/s11011-020-00629-9. View

19.

Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B . Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis. 2000; 7(6 Pt B):682-9. DOI: 10.1006/nbdi.2000.0321. View

20.

Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View